Cladribine
Formulations: - Oral > Solid > tablet: 10 mg Indications: - Multiple sclerosis Source: EML workbook import
Imported from EML workbook.
Formulations: - Oral > Solid > tablet: 10 mg Indications: - Multiple sclerosis Source: EML workbook import
Formulations: - Parenteral > General injections > SC: 20 mg per mL; 40 mg per mL Parenteral > General injections > SC: 20 mg per mL in pre-filled syringe; 40 mg per mL in pre-filled syringe Indications: - Relapsing-remitting multiple sclerosis - Multiple sclerosis Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 500 mg per 50 mL in 50 mL vial - Parenteral > General injections > IV: 100 mg per 10 mL in 10 mL vial; 500 mg per 50 mL in 50 mL vial Indications: - Multiple sclerosis - Follicular lymphoma - Diffuse large B-cell lymphoma, not otherwise specified - Chronic lymphocytic leukaemia or small lymphocytic lymphoma - Burkitt lymphoma including Burkitt leukaemia Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.